Lysophosphatidic acid-LPA1 receptor-Rho-Rho kinase-induced up-regulation of Nav1.7 sodium channel mRNA and protein in adrenal chromaffin cells: Enhancement of 22Na+ influx, 45Ca2+ influx and catecholamine secretion

Journal of Neurochemistry

Volumn 105, Issue 2, 2008, Pages 401-412

  Maruta, Toyoaki ^a   Yanagita, Toshihiko ^a   Matsuo, Kiyotaka ^b   Uezono, Yasuhito ^b   Satoh, Shinya ^a   Nemoto, Takayuki ^a   Yoshikawa, Norie ^a   Kobayashi, Hideyuki ^a   Takasaki, Mayumi ^a   Wada, Akihiko ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Adrenal chromaffin cell; Calcium channel; Catecholamine secretion; LPA 1 receptor Rho Rho kinase; Lysophosphatidic acid; Nav1.7 sodium channel up regulation

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALCIUM 45; CATECHOLAMINE; CYCLOHEXIMIDE; DACTINOMYCIN; EXOENZYME C3; KI 16425; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; MESSENGER RNA; NICOTINE; RHO FACTOR; RHO KINASE; RHO KINASE INHIBITOR; SAXITOXIN; SODIUM 22; UNCLASSIFIED DRUG; VERATRIDINE; VOLTAGE GATED SODIUM CHANNEL; CALCIUM; ENZYME INHIBITOR; LYSOPHOSPHOLIPID; RADIOISOTOPE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SODIUM; SODIUM CHANNEL;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SODIUM TRANSPORT; UPREGULATION; ADRENAL GLAND; ANIMAL; CATTLE; CELL CULTURE; CELL MEMBRANE POTENTIAL; CYTOLOGY; DRUG EFFECT; GENETICS; METABOLISM; METHODOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; SIGNAL TRANSDUCTION;

BOVINAE; PTYCHODISCUS;

ADRENAL GLANDS; ANIMALS; CALCIUM; CATECHOLAMINES; CATTLE; CELLS, CULTURED; CHROMAFFIN CELLS; ENZYME INHIBITORS; LYSOPHOSPHOLIPIDS; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; RADIOISOTOPES; RECEPTORS, LYSOPHOSPHATIDIC ACID; RHO GTP-BINDING PROTEINS; RHO-ASSOCIATED KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; SODIUM; SODIUM CHANNELS; UP-REGULATION; VERATRIDINE;

EID: 41749090689     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05143.x     Document Type: Article

References (65)

1. Black J. A., Liu S., Tanaka M., Cummins T. R. Waxman S. G. (2004) Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain. Pain 108, 237 247.
2. Catterall W. A., Goldin A. L. Waxman S. G. (2005) International union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol. Rev. 57, 397 409.
3. Cestèle S. Catterall W. A. (2000) Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie 82, 883 892.
4. Cestèle S., Khalifa R. B., Pelhate M., Rochat H. Gordon D. (1995) α-Scorpion toxins binding on rat brain and insect sodium channels reveal divergent allosteric modulations by brevetoxin and veratridine. J. Biol. Chem. 270, 15153 15161.
5. Coman I., Aigrot M. S., Seilhean D., Reynolds R., Girault J. A., Zalc B. Lubetzki C. (2006) Nodal, paranodal and juxtanodal axonal proteins during demyelination and remyelination in multiple sclerosis. Brain 129, 3186 3195.
6. A1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc. Natl Acad. Sci. USA 97, 13384 13389.
7. Contos J. J. A., Ishii I. Chun J. (2000b) Lysophosphatidic acid receptors. Mol. Pharmacol. 58, 1188 1196.
8. Cox J. J., Reimann F., Nicholas A. K. et al. (2006) An SCN9A channelopathy causes congenital inability to experience pain. Nature 444, 894 898.
9. Dubin A. E., Bahnson T., Weiner J. A., Fukushima N. Chun J. (1999) Lysophosphatidic acid stimulates neurotransmitter-like conductance changes that precede GABA and L-glutamate in early, presumptive cortical neuroblasts. J. Neurosci. 19, 1371 1381.
10. Fertleman C. R., Baker M. D., Parker K. A. et al. (2006) SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52, 767 774.
11. Fukushima N. (2004) LPA in neural cell development. J. Cell. Biochem. 92, 993 1003.
12. A1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid. Proc. Natl Acad. Sci. USA 95, 6151 6156.
13. Fukushima N., Weiner J. A. Chun J. (2000) Lysophosphatidic acid (LPA) is a novel extracellular regulator of cortical neuroblast morphology. Dev. Biol. 228, 6 18.
14. Fukushima N., Weiner J. A., Kaushal D., Contos J. J. A., Rehen S. K., Kingsbury M. A., Kim K. Y. Chun J. (2002) Lysophosphatidic acid influences the morphology and motility of young, postmitotic cortical neurons. Mol. Cell. Neurosci. 20, 271 282.
15. i/o pathway. Neurochem. Int. 50, 302 307.
16. Gardell S. E., Dubin A. E. Chun J. (2006) Emerging medicinal roles for lysophospholipid signaling. Trends Mol. Med. 12, 65 75.
17. Hamill O. P., Marty A., Neher E., Sakmann B. Sigworth F. J. (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391, 85 100.
18. Hecht J. H., Weiner J. A., Post S. R. Chun J. (1996) Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J. Cell Biol. 135, 1071 1083.
19. Hong S. Wiley J. W. (2006) Altered expression and function of sodium channels in large DRG neurons and myelinated A-fibers in early diabetic neuropathy in the rat. Biochem. Biophys. Res. Commun. 339, 652 660.
20. Hong S., Morrow T. J., Paulson P. E., Isom L. L. Wiley J. W. (2004) Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J. Biol. Chem. 279, 29341 29350.
21. Inoue M., Rashid M. H., Fujita R., Contos J. J. A., Chun J. Ueda H. (2004) Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nat. Med. 10, 712 718.
22. 3/EDG-7 in neuronal cell lines using a retrovirus expression system. Mol. Pharmacol. 58, 895 902.
23. Isom L. L. (2002) The role of sodium channels in cell adhesion. Front. Biosci. 7, 12 23.
24. + channels in cultured bovine adrenal medullary cells. J. Pharmacol. Exp. Ther. 302, 212 218.
25. Kingsbury M. A., Rehen S. K., Contos J. J. A., Higgins C. M. Chun J. (2003) Non-proliferative effects of lysophosphatidic acid enhance cortical growth and folding. Nat. Neurosci. 6, 1292 1299.
26. Klugbauer N., Lacinova L., Flockerzi V. Hofmann F. (1995) Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J. 14, 1084 1090.
27. 5. J. Biol. Chem. 281, 23589 23597.
28. Li Y., Gonzalez M. I., Meinkoth J. L., Field J., Kazanietz M. G. Tennekoon G. I. (2003) Lysophosphatidic acid promotes survival and differentiation of rat Schwann cells. J. Biol. Chem. 278, 9585 9591.
29. Lopez-Santiago L. F., Pertin M., Morisod X., Chen C., Hong S., Wiley J., Decosterd I. Isom L. L. (2006) Sodium channel β2 subunits regulate tetrodotoxin-sensitive sodium channels in small dorsal root ganglion neurons and modulate the response to pain. J. Neurosci. 26, 7984 7994.
30. LoTurco J. J., Owens D. F., Heath M. J., Davis M. B. Kriegstein A. R. (1995) GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 15, 1287 1298.
31. Martinez-Lavin M. (2004) Fibromyalgia as a sympathetically maintained pain syndrome. Curr. Pain Headache Rep. 8, 385 389.
32. van Meeteren L. A., Ruurs P., Christodoulou E., Goding J. W., Takakusa H., Kikuchi K., Perrakis A., Nagano T. Moolenaar W. H. (2005) Inhibition of autotaxin by lysophosphatidic acid and serine 1-phosphate. J. Biol. Chem. 280, 21155 21161.
33. Moolenaar W. H., van Meeteren L. A. Giepmans B. N. (2004) The ins and outs of lysophosphatidic acid signaling. Bioessays 26, 870 881.
34. v1.7 (PN1) in acute and inflammatory pain. Proc. Natl Acad. Sci. USA 101, 12706 12711.
35. + channel is expressed in glial cells. Proc. Natl Acad. Sci. USA 91, 9985 9989.
36. Pan C. -Y., Wu A. Z. Chen Y. -T. (2007) Lysophospholipids regulate excitability and exocytosis in cultured bovine chromaffin cells. J. Neurochem. 102, 944 956.
37. Pertin M., Ji R.-R., Berta T. et al. (2005) Upregulation of the voltage-gated sodium channel β2 subunit in neuropathic pain models: characterization of expression in injured and non-injured primary sensory neurons. J. Neurosci. 25, 10970 10980.
38. Sato K., Malchinkhuu E., Muraki T. et al. (2005) Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources. J. Neuroichem. 92, 904 914.
39. Savaskan N. E., Rocha L., Kotter M. R. et al. (2007) Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma. Cell. Mol. Life Sci. 64, 230 243.
40. Seishima M., Kanoh H., Izumi T., Niwa M., Matsuzaki Y., Takasu A., Ban M. Kitajima Y. (2000) A refractory case of secondary erythermalgia successfully treated with lumbar sympathetic ganglion block. Br. J. Dermatol. 143, 868 872.
41. Shiga T., Sakamoto A., Koizumi K. Ogawa R. (1999) Endoscopic thoracic sympathectomy for primary erythromelalgia in the upper extremities. Anesth. Analg. 88, 865 866.
42. Shiraishi S., Shibuya I., Uezono Y., Yokoo H., Toyohira Y., Yamamoto R., Yanagita T., Kobayashi H. Wada A. (2001a) Heterogeneous increases of cytoplasmic calcium: distinct effects on down-regulation of cell surface sodium channels and sodium channel subunit mRNA levels. Br. J. Pharmacol. 132, 1455 1466.
43. Shiraishi S., Yanagita T., Kobayashi H., Uezono Y., Yokoo H., Minami S., Takasaki M. Wada A. (2001b) Up-regulation of cell surface sodium channels by cyclosporin A, FK506, and rapamycin in adrenal chromaffin cells. J. Pharmacol. Exp. Ther. 297, 657 665.
44. Shiraishi S., Yokoo H., Yanagita T., Kobayashi H., Minami S., Saitoh T., Takasaki M. Wada A. (2003) Differential effects of bupivacaine enantiomers, ropivacaine and lidocaine on up-regulation of cell surface voltage-dependent sodium channels in adrenal chromaffin cells. Brain Res. 966, 175 184.
45. Smyth S. S., Sciorra V. A., Sigal Y. J., Pamuklar Z., Wang Z., Xu Y., Prestwich G. D. Morris A. J. (2003) Lipid phosphate phosphatases regulate lysophosphatidic acid production and signaling in platelets. Studies using chemical inhibitors of lipid phosphate phosphatase activity. J. Biol. Chem. 278, 43214 43223.
46. Toledo-Aral J. J., Moss B. L., He Z.-J. et al. (1997) Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc. Natl Acad. Sci. USA 94, 1527 1532.
47. Wada A. (2006) Roles of voltage-dependent sodium channels in neuronal development, pain, and neurodegeneration. J. Pharmacol. Sci. 102, 253 268.
48. 45Ca influx and secretion of catecholamines in cultured bovine adrenal medulla cells. Neuroscience 15, 283 292.
49. Wada A., Uezono Y., Arita M., Yuhi T., Kobayashi H., Yanagihara N. Izumi F. (1992) Cooperative modulation of voltage-dependent sodium channels by brevetoxin and classical neurotoxins in cultured bovine adrenal medullary cells. J. Pharmacol. Exp. Ther. 263, 1347 1351.
50. v1.7 sodium channels: mRNA stability and posttranscriptional control in adrenal chromaffin cells. Front. Biosci. 9, 1954 1966.
51. Waxman S. G. (2001) Transcriptional channelopathies: an emerging class of disorders. Nat. Rev. Neurosci. 2, 652 659.
52. Waxman S. G. Dib-Hajj S. (2005) Erythermalgia: molecular basis for an inherited pain syndrome. Trends Mol. Med. 11, 555 562.
53. + channel expression along axons in multiple sclerosis and its models. Trends Pharmacol. Sci. 25, 584 591.
54. Weiner J. A. Chun J. (1999) Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid. Proc. Natl Acad. Sci. USA 96, 5233 5238.
55. A1/edg-2 is expressed by mature oligodendrocytes during myelination in the postnatal murine brain. J. Comp. Neurol. 398, 587 598.
56. Weiner J. A., Fukushima N., Contos J. J. A., Scherer S. S. Chun J. (2001) Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling. J. Neurosci. 21, 7069 7078.
57. Xie Y., Gibbs T. C. Meier K. E. (2002) Lysophosphatidic acid as an autocrine and paracrine mediator. Biochim. Biophys. Acta 1582, 270 281.
58. Yamamoto R., Yanagita T., Kobayashi H., Yuhi T., Yokoo H. Wada A. (1996) Up-regulation of functional voltage-dependent sodium channels by insulin in cultured bovine adrenal chromaffin cells. J. Neurochem. 67, 1401 1408.
59. Yamamoto R., Yanagita T., Kobayashi H., Yokoo H. Wada A. (1997) Up-regulation of sodium channel subunit mRNAs and their cell surface expression by antiepileptic valproic acid: activation of calcium channel and catecholamine secretion in adrenal chromaffin cells. J. Neurochem. 68, 1655 1662.
60. 1-subunit mRNA levels in adrenal chromaffin cells. J. Neurochem. 73, 1749 1757.
61. Yanagita T., Kobayashi H., Yamamoto R., Kataoka H., Yokoo H., Shiraishi S., Minami S., Koono M. Wada A. (2000) Protein kinase C-α and -ε down-regulate cell surface sodium channels via differential mechanisms in adrenal chromaffin cells. J. Neurochem. 74, 1674 1684.
62. v1.7 sodium channel α-subunit mRNA by constitutive phosphorylation of extracellular signal-regulated kinase: negative regulation of steady-state level of cell surface functional sodium channels in adrenal chromaffin cells. Mol. Pharmacol. 63, 1125 1136.
63. v1.7 sodium channels in primary afferents. Hum. Gene Ther. 16, 271 277.
64. 2. J. Neurosci. 23, 7577 7585.
65. Yuhi T., Wada A., Kobayashi H., Yamamoto R., Yanagita T. Niina H. (1996) Up-regulation of functional voltage-dependent sodium channels by cyclic AMP-dependent protein kinase in adrenal medulla. Brain Res. 709, 37 43.